Acute interstitial nephritis due to mesalazine

Nephrology

Volumn 10, Issue 2, 2005, Pages 103-105

  Tadic, Mario ^a   Grgurevic, Ivica ^a   Scukanec Spoljar, Mira ^b   Bozic, Borka ^a   Marusic, Srecko ^a   Horvatic, Ivica ^a   Galesic, Kresimir ^a  

^a University of Zagreb School of Medicine   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Glomerulonephritis; Inflammatory bowel disease; Interstitial nephritis; Mesalazine; Monitoring renal function

Indexed keywords

ETHAMBUTOL; ISONIAZID; MESALAZINE; METHYLPREDNISOLONE; RIFAMPICIN;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; EOSINOPHILIA; FEVER; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ACUTE DISEASE; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; HUMANS; MALE; MESALAMINE; NEPHRITIS, INTERSTITIAL;

EID: 20144384740     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00376.x     Document Type: Article

References (13)

1. Ransford RAJ, Langman MJS. Sulphasalazine and mesalazine: Serious adverse reactions re-evaluated on the basis of suspected adverse reactions reports to the Committee on Safety of Medicines. Gut 2002; 51: 536-9.
2. Lewis JD. How safe are the safest IBD drug. Gastroenterology 2003; 124: 1986-8.
3. World MJ, Stevens PE, Ashton MA, Rainford DJ. Mesalazine-associated interstitial nephritis. Nephrol. Dial. Transplant. 1996; 11: 614-21.
4. Popoola J, Muller AF, Pollock L, O'Donnell P, Carmichael P, Stevens P. Late onset interstitial nephritis associated with mesalazine treatment. Br. Med. J. 1998; 317: 795-7.
5. Calvino J, Romero R, Pintos E et al. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease. Clin. Nephrol. 1998; 49: 265-67.
6. Mahmud N, Stinson J, O'Connell MA et al. Microalbuminuria in inflammatory bowel disease. Gut 1994; 35: 1599-604.
7. Van Staa TP, Travis S, Leufkens HG, Logan RF. 5-aminosalicylic acids and the risk of renal disease: A large British epidemiological study. Gastroenterolology 2004; 126: 1733-9.
8. Fraser JS, Muller AF, Smith DJ, Newman DJ, Lamb EJ. Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy. Aliment. Pharmacol. Ther. 2001; 15: 1131-7.
9. Moayyedi P, Fletcher S, Harnder P, Axon ATR, Brownjohn A. Mesangiocapillary glomerulonephritis associated with ulcerative colitis: Case report of two patients. Nephrol. Dial. Transplant. 1995; 10: 1923-4.
10. Thomas DM, Nicholls AJ, Feest TG. Ulcerative colitis and glomerulonephritis: Is there any association? Nephrol. Dial. Transplant. 1990; 5: 628-9.
11. Dhiman RK, Poddar U, Sharma BC et al. Membranous glomerulonephritis in association with ulcerative colitis. Indian J. Gastroenterol. 1998; 17: 62.
12. Birketvedt GS, Berg KJ, Fausa O, Florholmen J. Glomerular and tubular renal functions after long-term medication of sulfasalazine, olsalazine, and mesalazine in patients with ulcerative colitis. Inflamm. Bowel Dis. 2000; 6: 275-9.
13. Frandsen NE, Saugmann S, Marcussen N. Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease. Nephron 2002; 92: 200-2.